Multiparametric MRI–based Deep Learning and Radiomics for Evaluating Lymph Node Metastasis in Early-Stage Cervical Cancer
- 1 May 2026
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 8 (3) , e250345
Abstract
Radiomics and deep learning–radiomics fusion models constructed using tumor and pelvic lymph node features from MRI demonstrated favorable performance for preoperative lymph node metastasis prediction in early-stage cervical cancer.Keywords
Funding Information
- National Natural Science Foundation of China (82471943)
- Shanghai Jinshan District Health Committee (JSZK2023A02)
This publication has 25 references indexed in Scilit:
- Feasibility of T2WI-MRI-based radiomics nomogram for predicting normal-sized pelvic lymph node metastasis in cervical cancer patientsEuropean Radiology, 2021
- Feasibility of MRI-based radiomics features for predicting lymph node metastases and VEGF expression in cervical cancerEuropean Journal of Radiology, 2021
- Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: systematic review and meta-analysisEuropean Radiology, 2020
- Radiomics analysis of magnetic resonance imaging improves diagnostic performance of lymph node metastasis in patients with cervical cancerRadiotherapy and Oncology, 2019
- Radiomic signature as a predictive factor for lymph node metastasis in early‐stage cervical cancerJournal of Magnetic Resonance Imaging, 2018
- Beyond imaging: The promise of radiomicsPhysica Medica, 2017
- Complications of lymphadenectomy for gynecologic cancerEuropean Journal of Surgical Oncology, 2013
- Preoperative staging of cervical cancer: Is 18-FDG-PET/CT really effective in patients with early stage disease?Gynecologic Oncology, 2011
- Lymph node assessment in cervical cancer: Prognostic and therapeutic implicationsJournal of Surgical Oncology, 2008
- Audit of preoperative and early complications of laparoscopic lymph node dissection in 1000 gynecologic cancer patientsAmerican Journal of Obstetrics and Gynecology, 2006